puravida, you won't have to listen through the call. If Ariad decides to announce the new drug during the conference, they would certainly be required to issue a press release beforehand.
I'm not holding my breath on this, but if it happens it will be a pleasant surprise.
It would be nice if one of the analysts on the call would press HB as to the plans moving forward and, more importantly, how he intends to finance those plans.
rum
One more thing, it's just my guess, but I believe Ariad stock closes down on the day the new drug is announced (unless it is a real blockbuster). The reason is, I think the announcement will generate interest in Ariad, but investors will soon question how the company would pay to move the drug forward. The only answer, dilute.
